Filing Details
- Accession Number:
- 0001127602-14-015091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-23 19:25:22
- Reporting Period:
- 2014-04-21
- Filing Date:
- 2014-04-23
- Accepted Time:
- 2014-04-23 19:25:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1501399 | D Scott Sherman | 2525 Dupont Drive Irvine CA 92612 | Executive Vice President, Hr | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-21 | 4,500 | $73.04 | 12,723 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-21 | 4,500 | $139.85 | 8,223 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-04-22 | 10,000 | $75.58 | 18,223 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-22 | 10,000 | $163.00 | 8,223 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-04-21 | 4,500 | $0.00 | 4,500 | $73.04 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-04-22 | 10,000 | $0.00 | 10,000 | $75.58 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,000 | 2020-11-03 | No | 4 | M | Direct | |
20,000 | 2021-02-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,572 | Indirect | By 401(k) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 28, 2014.
- Shares allocated to reporting person's SIP account as of reporting date.
- The option becomes exercisable in four equal annual installments beginning November 3, 2011.
- The option becomes exercisable in four equal annual installments beginning February 17, 2012.